Publication Details
Abstract
Aim: To evaluate the efficacy of a probiotic consumption on gingivitis and to assess its impact on the subgingival microbiota.
Material and Methods: the study is a randomized clinical trial that conducted on 30 subjects divided two groups: 15 patients test group suffered from gingivitis who administered probiotic two oral tablets per day containing different probiotic bacterial strains for 20 days and 15 individual control group administered a placebo tab that resemble the probiotic tab. Clinical and microbiological examinations were carried out for 20 days at three stages: (0 day 10 days and 20 days). clinical examination included measurement of gingival (GI) &plaque (PI) indices microbiological examination by counting sub-gingival bacteria at the three stages follow up, the study was approved by the Research Ethics Committee of College of Dentistry University of Mosul with the reference number UoM. Dent/H.OM.61/22. Subjects attending the Faculty of periodontal disease, University of Mosul, College of Dentistry (Mosul, Iraq), from February to November 2022 were screened.
Result: Fredmans showed that there was no significant difference between the mean plaque & gingival indices (0.557, 0.078) respectively for control group conversely for test group who received probiotic supplement showed significant difference between the mean plaque & gingival indices (0.000, 0.000) after the follow up stages.